venlafaxine
- Product NDC
- 60760-304
- 11-digit product format
- 607600304
- Labeler code
- 60760
- Product ID
- 60760-304_a97d917a-6b6e-b9bd-e053-2a95a90afcce
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- venlafaxine hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA090555
- Marketing category
- ANDA
- Marketing start
- 2020-06-16
- Marketing end
- 0000-00-00
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60760-304 | VENLAFAXINE (VENLAFAXINE HYDROCHLORIDE) TABLET [ST. MARY'S MEDICAL PARK PHARMACY] | 1 | Legacy NDC | 20200708_a97dbc5e-7c19-58f9-e053-2995a90a1ad0.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-304-30 | 60760030430 | 30 TABLET in 1 BOTTLE, PLASTIC (60760-304-30) | 30 tablet | 2020-06-16 | 0000-00-00 | No | No | Current |